Thoughts on the new PE 22-28 preclinical data – worth watching?

Posted by weekendnate in Research & News - 3 points, 0 comments.

com/peptides/pe-22-28). The write‑up notes it’s a spadin‑derived TREK‑1 blocker showing fast antidepressant‑like effects and increased neurogenesis in animal models. From what I’ve seen in my own tracking, anything that claims rapid mood shifts tends to be noisy in human data, and the safety profile is still a big unknown. I’m curious if anyone has tried it in a low‑dose experimental protocol and noticed any subjective changes in mood or cognition without obvious side effects.

Community discussion - research and educational context only. Not medical advice.